The global HCL lincomycin market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). HCL lincomycin supports neutralizing the functions of bacteria by disabling their ability to form necessary proteins which let them survive. Thus, the growing prevalence of infection caused by bacteria is anticipated to spur market growth. HCL lincomycin is generally sold under the brand name linocyn. HCL lincomycin can either be injected into the patient’s body or administered orally. The market growth is also attributed to the growing prevalence of disorders that are caused by a wide range of bacteria such as Streptococcus pneumonia, Propionibacterium acne, Staphylococcus, and various others. 

As per the World Health Organization (WHO), pneumonia is the single largest infectious cause of mortalities in children all around the globe. The stats show that the disease killed 740,180 children under the age of 5 in 2019, accounting for 14% of all mortalities of children under 5 years old, however, 22% of all mortalities in children aged 1 to 5. Adding to this, the easy availability and the convenient access to lincomycin HCL antibiotic as an over-the-counter medication is further anticipated to propel the global lincomycin HCL market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Dosage Form
• By Age Group
• By Application

Regions covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape:  Baxter International Inc., and Pfizer Inc., among others.

• Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global HCL Lincomycin Market Report by Segment

By Dosage Form

• Capsules
• Tablets
• Injectables

By Age Group

• Pediatric
• Adults
• Geriatric

By Application

• Skin Infection
• Gastrointestinal Infection
• Respiratory Tract Infection
• Bone and Joint Infection
• Others

Global HCL Lincomycin Market Report by Region

North America       

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa